Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy

被引:184
|
作者
Kemi, Ole Johan [1 ,2 ]
Ceci, Marcello [3 ,4 ]
Wisloff, Ulrik [2 ,5 ]
Grimaldi, Serena [3 ,4 ]
Gallo, Paolo [3 ,4 ]
Smith, Godfrey L. [1 ]
Condorelli, Gianluigi [3 ,4 ,6 ]
Ellingsen, Oyvind [2 ,5 ]
机构
[1] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
[2] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway
[3] Ist Ricovero & Cura Carattere Sci Multimed, Milan, Italy
[4] Fdn Parco Sci San Raffaele, Rome, Italy
[5] St Olavs Hosp, Dept Cardiol, Trondheim, Norway
[6] Univ Calif San Diego, Div Cardiol, Dept Med, La Jolla, CA 92093 USA
关键词
D O I
10.1002/jcp.21197
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cardiomyocyte hypertrophy differs according to the stress exerted on the myocardium. While pressure overload-induced cardiomyocyte hypertrophy is associated with depressed contractile function, physiological hypertrophy after exercise training associates with preserved or increased inotropy. We determined the activation state of myocardial Akt signaling with downstream substrates and fetal gene reactivation in exercise-induced physiological and pressure overload-induced pathological hypertrophies. C57BL/6J mice were either treadmill trained for 6 weeks, 5 days/week, at 85-90% of maximal oxygen uptake (VO2max), or underwent transverse aortic constriction (TAC) for 1 or 8 weeks. Total and phosphorylated protein levels were determined with SDS-PAGE, and fetal genes by real-time RT-PCR. In the physiologically hypertrophied heart after exercise training, total Akt protein level was unchanged, but Akt was chronically hyperphosphorylated at serine 473. This was accompanied by activation of the mammalian target of rapamycin (mTOR), measured as phosphorylation of its two substrates: the ribosomal protein S6 kinase-I (S6KI) and the eukaryotic translation initiation factor-4E binding protein-I (4E-BPI). Exercise training did not reactivate the fetal gene program (beta-myosin heavy chain, atrial natriuretic factor, skeletal muscle actin). In contrast, pressure overload after TAC reactivated fetal genes already after I week, and partially inactivated the Akt/mTOR pathway and downstream substrates after 8 weeks. In conclusion, changes in opposite directions of the myocardial Akt/mTOR signal pathway appears to distinguish between physiological and pathological hypertrophies; exercise training associating with activation and pressure overload associating with inactivation of the Akt/mTOR pathway.
引用
收藏
页码:316 / 321
页数:6
相关论文
共 50 条
  • [1] Egr-1 mediated cardiac miR-99 family expression diverges physiological hypertrophy from pathological hypertrophy
    Ramasamy, Subbiah
    Velmurugan, Ganesan
    Rekha, Balakrishnan
    Anusha, Sivakumar
    Rajan, K. Shanmugha
    Shanmugarajan, Suresh
    Ramprasath, Tharmarajan
    Gopal, Pandi
    Tomar, Dhanendra
    Karthik, Karuppusamy V.
    Verma, Suresh Kumar
    Garikipati, Venkata Naga Srikanth
    Sudarsan, Rajan
    EXPERIMENTAL CELL RESEARCH, 2018, 365 (01) : 46 - 56
  • [2] Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways
    Ba Lina
    Gao Jingquan
    Chen Yunping
    Qi Hanping
    Dong Chonghui
    Pan Hao
    Zhang Qianhui
    Shi Pilong
    Song Chao
    Guan Xueying
    Cao Yonggang
    Sun Hongli
    PHYTOMEDICINE, 2019, 58
  • [3] Physiological and pathological cardiac hypertrophy
    Shimizu, Ippei
    Minamino, Tohru
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2016, 97 : 245 - 262
  • [4] Mechanisms for the transition from physiological to pathological cardiac hypertrophy
    Oldfield, Christopher J.
    Duhamel, Todd A.
    Dhalla, Naranjan S.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 98 (02) : 74 - 84
  • [5] Mechanisms of physiological and pathological cardiac hypertrophy
    Nakamura, Michinari
    Sadoshima, Junichi
    NATURE REVIEWS CARDIOLOGY, 2018, 15 (07) : 387 - 407
  • [6] Mechanisms of physiological and pathological cardiac hypertrophy
    Michinari Nakamura
    Junichi Sadoshima
    Nature Reviews Cardiology, 2018, 15 : 387 - 407
  • [7] Physiological activation of Akt by PHLPP1 deletion protects against pathological hypertrophy
    Moc, Courtney
    Taylor, Amy E.
    Chesini, Gino P.
    Zambrano, Cristina M.
    Barlow, Melissa S.
    Zhang, Xiaoxue
    Gustafsson, Asa B.
    Purcell, Nicole H.
    CARDIOVASCULAR RESEARCH, 2015, 105 (02) : 160 - 170
  • [8] Chronic Akt blockade aggravates pathological hypertrophy and inhibits physiological hypertrophy
    Buss, Sebastian J.
    Riffel, Johannes H.
    Malekar, Pratima
    Hagenmueller, Marco
    Asel, Christina
    Zhang, Min
    Weiss, Celine
    Katus, Hugo A.
    Hardt, Stefan E.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2012, 302 (02): : H420 - H430
  • [9] Chronic Akt Blockade Aggravates Pathological Hypertrophy and Inhibits Physiological Hypertrophy
    Riffel, Johannes H.
    Buss, Sebastian J.
    Hagenuller, Marco
    Weiss, Celine
    Katus, Hugo A.
    Hardt, Stefan E.
    CIRCULATION, 2010, 122 (21)
  • [10] Physiological and Pathological Role of mTOR Signaling in Astrocytes
    Hochmuth, Luise
    Hirrlinger, Johannes
    NEUROCHEMICAL RESEARCH, 2025, 50 (01)